Pages that link to "Q35745965"
Jump to navigation
Jump to search
The following pages link to Enhanced expression of cyclooxygenase-2 in high grade human transitional cell bladder carcinomas (Q35745965):
Displaying 50 items.
- Combination of celecoxib with percutaneous radiotherapy in patients with localised prostate cancer - a phase I study (Q28218423) (← links)
- Alterations in lipoxygenase and cyclooxygenase-2 catalytic activity and mRNA expression in prostate carcinoma (Q28360358) (← links)
- Non-steroidal anti-inflammatory drugs in the treatment of genitourinary malignancies: focus on clinical data (Q33304363) (← links)
- Cytotoxic necrotizing factor from Escherichia coli induces RhoA-dependent expression of the cyclooxygenase-2 Gene (Q33552763) (← links)
- Animal model of naturally occurring bladder cancer: characterization of four new canine transitional cell carcinoma cell lines (Q33849066) (← links)
- FGFR1-induced epithelial to mesenchymal transition through MAPK/PLCγ/COX-2-mediated mechanisms (Q34305855) (← links)
- Cyclooxygenase 2 selective inhibitors in cancer treatment and prevention (Q35011895) (← links)
- Therapeutic approaches to bladder cancer: identifying targets and mechanisms (Q35173065) (← links)
- Molecular prognostication in bladder cancer--a current perspective. (Q35175438) (← links)
- Expression of cyclooxygenase-2 in human transitional cell carcinoma of the urinary bladder (Q35746418) (← links)
- Disruption of prostaglandin E2 receptor EP4 impairs urinary concentration via decreasing aquaporin 2 in renal collecting ducts (Q35845853) (← links)
- Expression of Prostacyclin-Synthase in Human Breast Cancer: Negative Prognostic Factor and Protection against Cell Death In Vitro (Q35920285) (← links)
- Rationale for use of cyclooxygenase-2 inhibitors in prevention and treatment of bladder cancer (Q35921577) (← links)
- Inflammatory networks underlying colorectal cancer (Q35925068) (← links)
- Cyclooxygenase-2 expression in bladder cancer and patient prognosis: results from a large clinical cohort and meta-analysis. (Q36232504) (← links)
- Urothelial tumorigenesis: a tale of divergent pathways (Q36234720) (← links)
- Long-term NSAID use and incident urothelial cell carcinoma in the VITamins and Lifestyle (VITAL) study (Q36468046) (← links)
- More than structural cells, fibroblasts create and orchestrate the tumor microenvironment (Q36568993) (← links)
- Cytochrome P450 interactions in human cancers: new aspects considering CYP1B1. (Q36572566) (← links)
- COX-2 expression is associated with an aggressive phenotype in ductal carcinoma in situ (Q36694470) (← links)
- Cyclo-oxygenase-2 and its inhibition in cancer: is there a role? (Q36788347) (← links)
- Inflammation and cancer: how friendly is the relationship for cancer patients? (Q37316105) (← links)
- Chemoprevention in bladder cancer: What's new? (Q37472582) (← links)
- The current state of head and neck cancer gene therapy (Q37595513) (← links)
- Management of upper urinary tract urothelial carcinoma (Q37812609) (← links)
- Systematic review and meta-analysis of COX-2 expression and polymorphisms in prostate cancer (Q38051084) (← links)
- Study of arachidonic Acid pathway in human bladder tumor (Q38172928) (← links)
- Clinical and prognosis relevance of COX-2 expression in Tunisian patients with primary gastric adenocarcinoma (Q38901848) (← links)
- Adenovirus-mediated IL-24 confers radiosensitization to human lung adenocarcinoma in vitro and in vivo (Q38931872) (← links)
- Piroxicam inhibits Masitinib-induced cyclooxygenase 2 expression in oral squamous cell carcinoma cells in vitro (Q39015449) (← links)
- Reciprocal correlation between the expression of cyclooxygenase-2 and E-cadherin in human bladder transitional cell carcinomas (Q39687686) (← links)
- Expression of Ki-67 and COX-2 in patients with upper urinary tract urothelial carcinoma. (Q39860786) (← links)
- Etodolac, a selective cyclooxygenase-2 inhibitor, induces upregulation of E-cadherin and has antitumor effect on human bladder cancer cells in vitro and in vivo. (Q40017793) (← links)
- Photoperiod alters the time course of brain cyclooxygenase-2 expression in Siberian hamsters (Q40550652) (← links)
- Prostacyclin synthase: upregulation during renal development and in glomerular disease as well as its constitutive expression in cultured human mesangial cells (Q42183828) (← links)
- COX2/mPGES1/PGE2 pathway regulates PD-L1 expression in tumor-associated macrophages and myeloid-derived suppressor cells (Q42323954) (← links)
- Cyclooxygenase-2 and Survivin in Superficial Urothelial Carcinoma of the Bladder and Correlation with Intratumoural Microvessel Density (Q43672969) (← links)
- Influence of cigarette smoking on prostaglandin synthesis and cyclooxygenase-2 gene expression in human urinary bladder cancer (Q44115420) (← links)
- Expression of cyclooxygenase-2 and thromboxane synthase in non-neoplastic and neoplastic thyroid lesions. (Q45010465) (← links)
- Estrogen and progesterone receptors and cyclooxygenase-2 expression in endometrial cancer, endometrial hyperplasia, and normal endometrium (Q46465274) (← links)
- NS-398, a selective cyclooxygenase-2 inhibitor, reduces experimental bladder carcinoma outgrowth by inhibiting tumor cell proliferation (Q46648565) (← links)
- Possible role of cyclooxygenase-2 in schistosomal and non-schistosomal-associated bladder cancer. (Q46944489) (← links)
- Cyclooxygenase-2 promotes angiogenesis in pTa/T1 urothelial bladder carcinoma but does not predict recurrence (Q47675077) (← links)
- Arterial stiffness induces remodeling phenotypes in pulmonary artery smooth muscle cells via YAP/TAZ-mediated repression of cyclooxygenase-2. (Q47993375) (← links)
- Association of cyclooxygenase-2 expression with prognosis of stage T1 grade 3 bladder cancer. (Q48447804) (← links)
- Expression of cyclooxygenase-2 and transforming growth factor-beta1 in HCV-induced chronic liver disease and hepatocellular carcinoma (Q50187490) (← links)
- Differences in expression of uroplakin III, cytokeratin 7, and cyclooxygenase-2 in canine proliferative urothelial lesions of the urinary bladder. (Q53093929) (← links)
- Cyclooxygenase-2 expression increases with the stage and grade in transitional cell carcinoma of the urinary bladder. (Q53354820) (← links)
- Overexpression of CDC91L1 (PIG-U) in bladder urothelial cell carcinoma: correlation with clinical variables and prognostic significance. (Q53521507) (← links)
- Cyclooxygenase-2 expression in astrocytomas. Relationship with microvascular parameters, angiogenic factors expression and survival. (Q55469726) (← links)